rxpros tirzepatide ProRx tirzepatide: FDA recalls, safety concerns, and what you need to know Compounded Tirzepatide Program | Medical

Hemoglobin A1c reduction with the GLP-1 receptor agonist semaglutide is independent of baseline eGFR: post hoc analysis of the sustain and pioneer programs

You want access to FDA-approved formulations sooner

[1] This means patients can use any of the approved sites without needing to adjust their dose or timing

Meta-analysis: pharmacologic treatment of restricted and repetitive behaviors in autism spectrum disorders

Update units at every dose escalation

Concurrent use of other medications known to promote weight gainsuch as certain antidepressants (particularly mirtazapine and some selective serotonin reuptake inhibitors), antipsychotics, corticosteroids, beta-blockers, or insulinmay counteract semaglutide's weight-reducing effects